MONTVALE, N.J., May 24 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that members of its management team are scheduled to present a corporate update at the following investor conferences.
Stephen R. Murray, M.D., Ph.D., Vice President, Clinical Development, will present at the Friedman, Billings, Ramsey & Co. 2007 Growth Conference on Thursday, May 31, 2007 at 8:15 a.m. Eastern Time at the Grand Hyatt New York Hotel in New York City.
James R. Sulat, President and Chief Executive Officer, will present at the Bank of America 2007 Healthcare Conference on Thursday, May 31, 2007 at 4:00 p.m. Pacific Time (7:00 p.m. Eastern Time) at the Four Seasons Hotel in Las Vegas, Nevada.
Interested parties may access the live webcasts of the presentations by visiting the "Investors" section of Memory Pharmaceuticals' website at http://www.memorypharma.com. Archived versions of the webcasts will be available at the same location for one week following the presentation.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.CONTACT: Jzaneen Lalani, General Counsel of Memory Pharmaceuticals Corp.,+1-201-802-7249; or Laura Perry of Stern Investor Relations, Inc. forMemory Pharmaceuticals Corp., +1-212-362-1200
Web site: http://www.memorypharma.com//
